# CytomX Therapeutics, Inc.: Form DEF 14A, filed Apr 27, 2023

- Company: [CytomX Therapeutics, Inc.](/companies/ctmx.md) (CIK 1501989)
- Form: DEF 14A
- Filed: 2023-04-27
- Accepted by EDGAR: Apr 27, 2023, 16:16 ET
- Period: 2023-06-14
- Accession: 0001140361-23-020944
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1501989/000114036123020944/ny20007703x1_def14a.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1501989/000114036123020944/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1501989/000114036123020944/ny20007703x1_def14a.htm

Filed Apr 27, 2023.
Source: SEC EDGAR, the filing index for accession 0001140361-23-020944. Last ingested by Listed: Nov 5, 2026, 17:07 ET. No prices; not investment advice.